Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-03-11

Clinical Trial Update: L-leucine in Diamond Blackfan Anemia Patients [Phase 2]

View source ↗

Summary

This document reports an ongoing Phase 2 clinical trial evaluating L-leucine in patients with Diamond Blackfan Anemia, but the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • L-leucine (L-leucine)

Snippet

Sponsor: Federal Scientific Clinical Centre of Pediatric Hematology, Oncology and Immunology named after Dmitry Rogache | Conditions: Diamond Blackfan Anemia | Phase 2 | Status: UNKNOWN